The global Needlefree Closed System Transfer Device (CSTD) market was valued at 331.6 Million USD in 2021 and will grow with a CAGR of 19.94% from 2021 to 2027, based on Research newly published report.

The prime objective of this report is to provide the insights on the post COVID-19 impact wwhich will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).

Closed System Transfer Device (CSTD) is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system, which designed to prevent the escape of hazardous drug vapors into the environment during drug reconstitution and administration.Millions of healthcare workers are exposed to chemotherapy and other hazardous drugs annually. Studies have shown that exposure to these hazardous drugs can cause serious health problems, such as cancer, reproductive and development problems and other adverse effects that can be irreversible even after low-level exposures, according to the Occupational Safety & Health Administration (OSHA), National Institute of Occupational Safety & Health (NIOSH), and Joint Commission. So, Potential market is huge in the future.

By Market Verdors:

By Types:

By Applications:

Key Indicators Analysed

 

Key Reasons to Purchase

LEAVE A REPLY

Please enter your comment!
Please enter your name here